Myogenic-induced mesenchymal stem cells are capable of modulating the immune response by regulatory T cells

Cell therapy for patients who have intractable muscle disorders may require highly regenerative cells from young, healthy allogeneic donors. Mesenchymal stem cells are currently under clinical investigation because they are known to induce muscle regeneration and believed to be immune privileged, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Sunyoung, Lim, Hyun Ju, Jackson, John D, Atala, Anthony, Yoo, James J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927963/
https://www.ncbi.nlm.nih.gov/pubmed/24555015
http://dx.doi.org/10.1177/2041731414524758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927963/
https://www.ncbi.nlm.nih.gov/pubmed/24555015
http://dx.doi.org/10.1177/2041731414524758

Ejemplares similares